• Short video platform TikTok has pledged US$ 10 million to support Gavi’s life-saving immunisation programmes and future deployment of COVID-19 vaccines
  • The donation will be matched by the Bill & Melinda Gates Foundation through the Gavi Matching Fund, a public-private funding mechanism to support Gavi programmes
  • Dr Seth Berkley: “Working with global innovators such as TikTok lies at the heart of Gavi’s public-private partnership model.”

Geneva, 29 April 2020 – TikTok will contribute US$ 10 million to Gavi, the Vaccine Alliance to support Gavi’s response to the COVID-19 pandemic in lower-income countries in Africa. The donation will be matched by the Bill & Melinda Gates Foundation through the Gavi Matching Fund, a public-private funding mechanism to support Gavi programmes.   

“This important contribution to Gavi will not only help us to deploy vaccines, once developed, against COVID-19, but it will also help us prevent a potentially catastrophic impact on immunisation programmes across the developing world,” said Dr Seth Berkley, CEO of Gavi. “Working with global innovators such as TikTok lies at the heart of Gavi’s public-private partnership model. The results we’ve achieved over the past two decades have only been possible thanks to the unique combination of expertise from our global public sector partners and the business acumen, creativity and entrepreneurship of the private sector. We thank TikTok for their support and the work they are doing in combating COVID-19, and look forward to even closer collaboration in the future.”

Drawing upon the power of its public-private partnership model and by leveraging private sector resources, technology and agility, Gavi is uniquely positioned to support countries in responding to disruptions and challenges posed by the COVID-19 pandemic. From logistics, financial services and technology companies to social media platforms, like TikTok, Gavi’s private sector partners are stepping up their support to protect the health workforce and communities, contain the outbreak and prepare the health system for what is ahead.

“TikTok was created to inspire creativity and bring joy to the community. In the face of this unprecedented crisis, we are committed to playing our part in the global outpouring of mutual support and giving, and providing concrete relief for those most affected. We believe this support can go a long way in the improvement of a robust and sustainable immunisation programme in African countries, in particular ensuring equal access to the future COVID-19 vaccines, making a real difference to the health and safety of the African community in the long term,” said TikTok.

Gavi was established in 2000 to ensure new and underused vaccines are quickly made available to prevent infectious diseases and strengthen global health security. In addition to having helped immunise 760 million people in the past 20 years, with a further 900 million immunised through campaigns, Gavi has also supported 496 vaccine introductions and campaigns in the world’s 73 poorest countries and established global vaccine stockpiles against major health threats, such as Ebola.


COVID-19 related

Vaccines that use harmless viruses as a delivery mechanism are vulnerable to being attacked by our immune system – but experimenting with how they are given could get around this.

A medical professor explains the reasoning behind the delay in the UK and what impact this might have on the vaccine's effectiveness.

COVAX announced the signing of an advance purchase agreement for up to 40 million doses of the Pfizer-BioNTech vaccine; rollout to commence with successful execution of supply agreements.

Some people continue to shed viral RNA for weeks or months after developing COVID-19. Could persistent pockets of infection be to blame?

New review of evidence on a single-dose HPV vaccination schedule is published by PATH-led consortium.

African leaders can make strategies to fight COVID-19 more accessible to the people.

Scientists around the world are working faster than ever to find vaccines that could stop the spread of COVID-19. Now, nearly a year on since the emergence of this new coronavirus, we have several promising vaccines candidates, one of which has…

Subscribe to our newsletter